Mature Mothers’ Children Experience Increased Autism Risk

A 10 year investigation analyzing 4.9 million births in the 1990s discovered additional proof that there exists a link involving autism and the actual...

Combating Hair Loss in Women

Quite a few women having hair loss endure in silence, changing their hairstyle in order to conceal thinning hair or patches. However the faster...

Female Viagra

Research Indicates Flibanserin Reduces Distress and Improves Satisfaction for many Women Having Decreased Sexual Drive. Flibanserin, a type of antidepressant medication, can make sex much...

New Magazine Helps Capture the Essence of an Inner and Outer GLOW

Well-known publisher in the beauty and wellness industry, Anne Akers, takes on a new venture with the recent launch of GLOW Beauty Magazine. Encompassing...

Hope for the Journey — Women’s Health Research at VA

For more than a decade, the Department of Veterans Affairs (VA) has made women's gender-specific health care needs a major priority. VA researchers...

Procter & Gamble’s My Black is Beautiful Honored With City of Cincinnati Proclamation

Procter & Gamble (NYSE: PG), today expressed deep appreciation and delight that Mark Mallory, Mayor of Cincinnati, and Ohio State Senator Eric Kearney declared...

Breast Enhancement Surgeon in Connecticut Performs Mommy Makeovers for Unique Needs of Mothers over...

Post-pregnancy plastic surgery is growing in popularity with women over 40, according to board-certified plastic surgeon Dr. Ellen Mahony (www.drellenmahony.com). She says that combined...

Menopause: Coping with Hot Flashes

(HealthAndFitnessTimes.com)     Nearly all women have hot flashes at some time prior to or following menopause, when their levels of estrogen are decreasing. While a...

Abviva Details Patent Information for its Breast Cancer Risk Assessment Technology

Abviva, Inc. (Pink Sheets: ABVV), a biomedical company engaged in the development and commercialization of breast cancer related applications of Mammastatin, today provided further...

Boehringer Ingelheim Announces New Data on Flibanserin in Pre-Menopausal Women with Hypoactive Sexual Desire...

Data from pivotal Phase III clinical trials demonstrate that a higher proportion of pre-menopausal women with Hypoactive Sexual Desire Disorder (HSDD) receiving flibanserin 100mg...